Navigation Links
Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
Date:8/7/2008

KOBE, Japan, Aug. 8 /PRNewswire/ -- Carna Biosciences, Inc. ("Carna") is pleased to announce the signing of a collaborative agreement with Caliper Life Sciences, Inc. USA ("Caliper") on August 6 (US Eastern Daylight Time). Carna will supply a set of discrete protein kinases aiding the expansion of Caliper's kinase profiling and assay development services, and ProfilerPro Kinase Selectivity Assay Kits. Caliper's products and services are widely used and highly regarded by leading pharmaceutical and biotech companies. The selection of Carna as a Preferred Provider enhances the visibility and use of Carna's products in the area of kinase inhibitor drug discovery -- a major focus of targeted therapy in the areas of cancer, neurological, and autoimmune diseases.

"I am proud of the expression and purification technologies that Carna has developed in order to produce nearly 300 human kinases to date, and even more pleased that Caliper has selected Carna Biosciences as a principle supplier for Caliper's ProfilerPro Kits," said Kohichiro Yoshino, President and CEO of Carna Biosciences. "Caliper is an established and reliable partner to the pharmaceutical and biotech industry.

Working with Caliper provides Carna with access to a wealth of new opportunities to expand sales of protein kinases throughout the worldwide market. This synergistic impact of combining Caliper's advanced instrumentation with the wide selection and premier quality reagents provided by Carna will greatly benefit both companies and their clients. We anticipate that this expanded relationship with Caliper will further position us to explore R&D Partnerships with global biopharmaceutical companies.

About Carna Biosciences, Inc.

Carna Biosciences, Inc. (http://www.carnabio.com), founded in April 2003, is a Japanese biotechnology company conducting intercellular signaling-based drug discovery programs, as well as providing
'/>"/>

SOURCE Carna Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
3. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
4. NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER
5. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
6. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
7. Neurocrine Biosciences Reports Second Quarter 2008 Results
8. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
10. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
11. SuperArray Bioscience Changes Name to SABiosciences and Moves Into New Larger Facility on Verge of Tenth Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited ... the DisrupTOR-1 trial of BNC105 in patients with metastatic ... Orlando, Florida . The data will ... the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 ...
(Date:2/27/2015)... Feb. 27, 2015  Steep Hill, the industry leader ... internationally, intends to open a full service medical cannabis ... , bringing advanced scientific tools and methodology to ... Steep Hill is currently the only laboratory licensed by ... and contaminant testing in order to meet the recently ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading personal ... Black as Privacy Officer and Corporate Counsel. Black ... privacy laws as well as health care regulations. As ... will be responsible for reviewing, updating and enhancing the ... U.S. and abroad. She joined the company January 5, ...
(Date:2/26/2015)... , Feb. 26, 2015 Protiviti ( ... latest version of the Governance Portal , designed ... risk and compliance (GRC) tasks across multiple business units ... updated to help customers better align their controls with ... Treadway Commission ) requirements. In response to client feedback, ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 223andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... AMES, Iowa, Jan. 21, 2011 NewLink Genetics Corporation ... clinical trial of the company,s investigational HyperAcute® Pancreas cancer ... the American Society of Clinical Oncology 2011 Gastrointestinal Cancers ... poster is below. Title: Effect of ...
... 20 /PRNewswire/ - YM BioSciences Inc. (NYSE Amex: YMI, ... a diverse portfolio of promising hematology and cancer-related products ... were reported from a randomized Phase II gastric cancer ... Sankyo Co., Ltd. in Japan and Kuhnil Pharma Co. ...
... OF PRUSSIA, Pa., Jan. 20, 2011 CSL ... biotherapies industry and a subsidiary of CSL Limited ... to six patient organizations through the Local Empowerment for ... advocacy efforts of organizations committed to helping people who ...
Cached Biology Technology:NewLink Genetics to Present Phase 2 Data of Its HyperAcute® Pancreas Immunotherapy at ASCO 2011 Gastrointestinal Cancers Symposium 2NewLink Genetics to Present Phase 2 Data of Its HyperAcute® Pancreas Immunotherapy at ASCO 2011 Gastrointestinal Cancers Symposium 3NewLink Genetics to Present Phase 2 Data of Its HyperAcute® Pancreas Immunotherapy at ASCO 2011 Gastrointestinal Cancers Symposium 4YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium 2YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium 3YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium 4CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington 2CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington 3CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington 4
(Date:2/19/2015)... , Feb .19, 2015 Research and Markets ... addition of the "Military Electro-Optical / Infrared ... Technology, by Platform - Forecast to 2020" ... military electro-optical/infrared systems market is expected to reach ... of 7.71%. This report segments the ...
(Date:2/12/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announced ... DISTRIBUTED METHOD AND SYSTEM TO IMPROVE COLLABORATIVE ... establishes NXT-ID,s position in the emerging "Internet of Things" ... for multiple devices to collaborate with one another to ...
(Date:2/5/2015)... North Carolina , 5. Februar 2015 ... Jahr als spezialisiertes Logistikunternehmen und hat eine ... einzige klinische Logistikfirma (Clinical Logistics Organization – ... der neuen Kampagne lautet First , ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... , Aug. 4 BIO-key International, Inc. (OTC Bulletin Board: ... be showcasing its fingerprint biometric solutions at the Allscripts 2010 Client Experience Conference ... August 5-7, 2010 . , , ... (Logo: http://photos.prnewswire.com/prnh/20050509/BIOKEYLOGO ) , , ...
... known affectionately as a snot otter or devil ... species. For unexplained reasons, most hellbender populations have rapidly ... decades. Working with researchers from the Nashville ... State University are helping develop conservation techniques to sample ...
... This release is also available in Chinese . ... the anti-sunscreen. That,s more or less the description of what ... substances that could be added to photovoltaic materials in order ... Research reported in the journal Applied ...
Cached Biology News:BIO-key® International to Exhibit at Allscripts 2010 Client Experience Conference 2BIO-key® International to Exhibit at Allscripts 2010 Client Experience Conference 3Preserving sperm vital to saving 'snot otter' salamanders 2Selenium makes more efficient solar cells 2
... Source: Calf thymus Description: Topoisomerase I ... a transient breakage and rejoining of phosphodiester bonds ... allows molecules to be differentiated by a single ... I is active in the absence of Mn ...
... DNA Polymerase I catalyzes the template-directed polymerization ... 5?3 direction. DNA Polymerase I possesses a ... lowers the error rate during DNA replication, ... which enables the enzyme to replace nucleotides ...
Request Info...
supplied with 10x reaction buffer...
Biology Products: